Primary Myelofibrosis (PMF) Completed Phase 3 Trials for Momelotinib (DB11763)

Also known as: Primary Myelofibrosis / Primary Myelofibrosis (MF) / Myelofibrosis (PMF) / Myelofibrosis, Primary / PMF / Osteomyelofibrosis / Primary myelofibrosis (disorder) / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality)

IndicationStatusPhase
DBCOND0044387 (Primary Myelofibrosis (PMF))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02101268Efficacy of Momelotinib Versus Best Available Therapy in Anemic or Thrombocytopenic Subjects With Primary Myelofibrosis (MF), Post-polycythemia Vera MF, or Post-essential Thrombocythemia MFTreatment
NCT04173494A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)Treatment
NCT01969838Momelotinib Versus Ruxolitinib in Subjects With MyelofibrosisTreatment